BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yanagawa H, Sone S, Takahashi Y, Haku T, Yano S, Shinohara T, Ogura T. Serum levels of interleukin 6 in patients with lung cancer. Br J Cancer. 1995;71:1095-1098. [PMID: 7734307 DOI: 10.1038/bjc.1995.212] [Cited by in Crossref: 122] [Cited by in F6Publishing: 116] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Takemura Y, Sasaki M, Goto K, Takaoka A, Ohi A, Kurihara M, Nakanishi N, Nakano Y, Hanaoka J. Energy metabolism and nutritional status in hospitalized patients with lung cancer. J Clin Biochem Nutr 2016;59:122-9. [PMID: 27698539 DOI: 10.3164/jcbn.16-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
2 Metodieva SN, Nikolova DN, Cherneva RV, Dimova II, Petrov DB, Toncheva DI. Expression Analysis of Angiogenesis-Related Genes in Bulgarian Patients with Early-Stage Non-Small Cell Lung Cancer. Tumori 2011;97:86-94. [DOI: 10.1177/030089161109700116] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 5.3] [Reference Citation Analysis]
3 Shakeri A, Jarad NA, Terryberry J, Khan S, Leung A, Chen S, Didar TF. Antibody Micropatterned Lubricant‐Infused Biosensors Enable Sub‐Picogram Immunofluorescence Detection of Interleukin 6 in Human Whole Plasma. Small 2020;16:2003844. [DOI: 10.1002/smll.202003844] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Fukuura T, Miki C, Inoue T, Matsumoto K, Suzuki H. Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma. Br J Cancer. 1998;78:454-459. [PMID: 9716026 DOI: 10.1038/bjc.1998.514] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 2.5] [Reference Citation Analysis]
5 Seike M, Yanaihara N, Bowman ED, Zanetti KA, Budhu A, Kumamoto K, Mechanic LE, Matsumoto S, Yokota J, Shibata T, Sugimura H, Gemma A, Kudoh S, Wang XW, Harris CC. Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. J Natl Cancer Inst 2007;99:1257-69. [PMID: 17686824 DOI: 10.1093/jnci/djm083] [Cited by in Crossref: 100] [Cited by in F6Publishing: 79] [Article Influence: 7.1] [Reference Citation Analysis]
6 Tertiş M, Melinte G, Ciui B, Şimon I, Ştiufiuc R, Săndulescu R, Cristea C. A Novel Label Free Electrochemical Magnetoimmunosensor for Human Interleukin-6 Quantification in Serum. Electroanalysis 2019;31:282-92. [DOI: 10.1002/elan.201800620] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Makino Y, Yoon JH, Bae E, Kato M, Miyazawa K, Ohira T, Ikeda N, Kuroda M, Mamura M. Repression of Smad3 by Stat3 and c-Ski/SnoN induces gefitinib resistance in lung adenocarcinoma. Biochem Biophys Res Commun 2017;484:269-77. [PMID: 28115165 DOI: 10.1016/j.bbrc.2017.01.093] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
8 Yamaguchi T, Yamamoto Y, Yokota S, Nakagawa M, Ito M, Ogura T. Involvement of interleukin-6 in the elevation of plasma fibrinogen levels in lung cancer patients. Jpn J Clin Oncol. 1998;28:740-744. [PMID: 9879291 DOI: 10.1093/jjco/28.12.740] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 2.2] [Reference Citation Analysis]
9 Kuang Y, Guo W, Ling J, Xu D, Liao Y, Zhao H, Du X, Wang H, Xu M, Song H, Wang T, Jing B, Li K, Hu M, Wu W, Deng J, Wang Q. Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathway. Cell Death Dis 2019;10:297. [PMID: 30931929 DOI: 10.1038/s41419-019-1528-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
10 Couldwell G, Machlus KR. Modulation of megakaryopoiesis and platelet production during inflammation. Thromb Res 2019;179:114-20. [PMID: 31128560 DOI: 10.1016/j.thromres.2019.05.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
11 Zhou B, Liu J, Wang ZM, Xi T. C-reactive protein, interleukin 6 and lung cancer risk: a meta-analysis. PLoS One 2012;7:e43075. [PMID: 22912790 DOI: 10.1371/journal.pone.0043075] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
12 Peebles KA, Lee JM, Mao JT, Hazra S, Reckamp KL, Krysan K, Dohadwala M, Heinrich EL, Walser TC, Cui X, Baratelli FE, Garon E, Sharma S, Dubinett SM. Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Rev Anticancer Ther 2007;7:1405-21. [PMID: 17944566 DOI: 10.1586/14737140.7.10.1405] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
13 Koh E, Iizasa T, Yamaji H, Sekine Y, Hiroshima K, Yoshino I, Fujisawa T. Significance of the correlation between the expression of interleukin 6 and clinical features in patients with non-small cell lung cancer. Int J Surg Pathol 2012;20:233-9. [PMID: 22334615 DOI: 10.1177/1066896911436274] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
14 Soresi M, Giannitrapani L, D'Antona F, Florena AM, La Spada E, Terranova A, Cervello M, D'Alessandro N, Montalto G. Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. World J Gastroenterol 2006;12:2563-8. [PMID: 16688802 DOI: 10.3748/wjg.v12.i16.2563] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 66] [Article Influence: 4.3] [Reference Citation Analysis]
15 Chang K, Tsai C, Chiou Y, Chiu C, Jeng K, Huang CF. IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells. American Journal of Physiology-Lung Cellular and Molecular Physiology 2005;289:L446-53. [DOI: 10.1152/ajplung.00089.2005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
16 Harada D, Takigawa N, Kiura K. The Role of STAT3 in Non-Small Cell Lung Cancer. Cancers (Basel) 2014;6:708-22. [PMID: 24675568 DOI: 10.3390/cancers6020708] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 14.1] [Reference Citation Analysis]
17 Vilema-Enríquez G, Arroyo A, Grijalva M, Amador-Zafra RI, Camacho J. Molecular and Cellular Effects of Hydrogen Peroxide on Human Lung Cancer Cells: Potential Therapeutic Implications. Oxid Med Cell Longev 2016;2016:1908164. [PMID: 27375834 DOI: 10.1155/2016/1908164] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 8.4] [Reference Citation Analysis]
18 Healy C, Munoz-Wolf N, Strydom J, Faherty L, Williams NC, Kenny S, Donnelly SC, Cloonan SM. Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease. Respir Res 2021;22:133. [PMID: 33926483 DOI: 10.1186/s12931-021-01722-y] [Reference Citation Analysis]
19 Tijerina AJ. The biochemical basis of metabolism in cancer cachexia. Dimens Crit Care Nurs 2004;23:237-43. [PMID: 15586034 DOI: 10.1097/00003465-200411000-00001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
20 Sparano A, Lathers DMR, Achille N, Petruzzelli GJ, Young MRI. Modulation of Th1 and Th2 Cytokine Profiles and Their Association with Advanced Head and Neck Squamous Cell Carcinoma. Otolaryngol Head Neck Surg 2004;131:573-6. [DOI: 10.1016/j.otohns.2004.03.016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 9.2] [Reference Citation Analysis]
21 Yeh KY, Li YY, Hsieh LL, Chen JR, Tang RP. The -174 G/C polymorphism in interleukin-6 (IL-6) promoter region is associated with serum IL-6 and carcinoembryonic antigen levels in patients with colorectal cancers in Taiwan. J Clin Immunol 2010;30:53-9. [PMID: 19728052 DOI: 10.1007/s10875-009-9324-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
22 McKeown DJ, Brown DJ, Kelly A, Wallace AM, McMillan DC. The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer. Br J Cancer 2004;91:1993-5. [PMID: 15570310 DOI: 10.1038/sj.bjc.6602248] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 4.8] [Reference Citation Analysis]
23 Zhan SJ, Liu B, Linghu H. Identifying genes as potential prognostic indicators in patients with serous ovarian cancer resistant to carboplatin using integrated bioinformatics analysis. Oncol Rep 2018;39:2653-63. [PMID: 29693178 DOI: 10.3892/or.2018.6383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
24 Brichory FM, Misek DE, Yim AM, Krause MC, Giordano TJ, Beer DG, Hanash SM. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci USA. 2001;98:9824-9829. [PMID: 11504947 DOI: 10.1073/pnas.171320598] [Cited by in Crossref: 217] [Cited by in F6Publishing: 190] [Article Influence: 10.9] [Reference Citation Analysis]
25 Yonemori K, Tateishi U, Uno H, Yonemori Y, Tsuta K, Takeuchi M, Matsuno Y, Fujiwara Y, Asamura H, Kusumoto M. Development and validation of diagnostic prediction model for solitary pulmonary nodules. Respirology 2007;12:856-62. [PMID: 17986114 DOI: 10.1111/j.1440-1843.2007.01158.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
26 Ortegel JW, Staren ED, Faber LP, Warren WH, Braun DP. Modulation of tumor-infiltrating lymphocyte cytolytic activity against human non-small cell lung cancer. Lung Cancer 2002;36:17-25. [PMID: 11891029 DOI: 10.1016/s0169-5002(01)00472-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
27 Nixon LS, Yung B, Bell SC, Elborn JS, Shale DJ. Circulating immunoreactive interleukin-6 in cystic fibrosis. Am J Respir Crit Care Med 1998;157:1764-9. [PMID: 9620903 DOI: 10.1164/ajrccm.157.6.9704086] [Cited by in Crossref: 90] [Cited by in F6Publishing: 88] [Article Influence: 3.9] [Reference Citation Analysis]
28 Crohns M, Saarelainen S, Laine S, Poussa T, Alho H, Kellokumpu-lehtinen P. Cytokines in bronchoalveolar lavage fluid and serum of lung cancer patients during radiotherapy — Association of interleukin-8 and VEGF with survival. Cytokine 2010;50:30-6. [DOI: 10.1016/j.cyto.2009.11.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
29 Xu B, Chen Q, Yue C, Lan L, Jiang J, Shen Y, Lu B. Prognostic value of IL-6R mRNA in lung adenocarcinoma and squamous cell carcinoma. Oncol Lett 2018;16:2935-48. [PMID: 30127882 DOI: 10.3892/ol.2018.9044] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Lierova A, Jelicova M, Nemcova M, Proksova M, Pejchal J, Zarybnicka L, Sinkorova Z. Cytokines and radiation-induced pulmonary injuries. J Radiat Res 2018;59:709-53. [PMID: 30169853 DOI: 10.1093/jrr/rry067] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
31 Bihl M, Tamm M, Nauck M, Wieland H, Perruchoud AP, Roth M. Proliferation of Human Non–Small-Cell Lung Cancer Cell Lines: Role of Interleukin-6. Am J Respir Cell Mol Biol 1998;19:606-12. [DOI: 10.1165/ajrcmb.19.4.3247] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 1.7] [Reference Citation Analysis]
32 Zhang F, Duan S, Tsai Y, Keng PC, Chen Y, Lee SO, Chen Y. Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer. Cancer Sci 2016;107:746-54. [PMID: 27009878 DOI: 10.1111/cas.12937] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
33 Chang K, Huang CF, Tsai C, Chiu C, Lok Y. Role of IL-6 in neuroendocrine differentiation and chemosensitivity of non-small cell lung cancer. American Journal of Physiology-Lung Cellular and Molecular Physiology 2005;289:L438-45. [DOI: 10.1152/ajplung.00033.2005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
34 Dutta P, Sabri N, Li J, Li WX. Role of STAT3 in lung cancer. JAKSTAT 2014;3:e999503. [PMID: 26413424 DOI: 10.1080/21623996.2014.999503] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
35 Nikiteas NI, Tzanakis N, Gazouli M, Rallis G, Daniilidis K, Theodoropoulos G, Kostakis A, Peros G. Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol. 2005;11:1639-1643. [PMID: 15786541 DOI: 10.3748/wjg.v11.i11.1639] [Cited by in CrossRef: 88] [Cited by in F6Publishing: 82] [Article Influence: 5.5] [Reference Citation Analysis]
36 Quinchia J, Echeverri D, Cruz-Pacheco AF, Maldonado ME, Orozco J. Electrochemical Biosensors for Determination of Colorectal Tumor Biomarkers. Micromachines (Basel) 2020;11:E411. [PMID: 32295170 DOI: 10.3390/mi11040411] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
37 Li YY, Chang JW, Hsieh LL, Yeh KY. Neutralization of interleukin (IL)-10 released by monocytes/macrophages enhances the up-regulatory effect of monocyte/macrophage-derived IL-6 on expressions of IL-6 and MUC1, and migration in HT-29 colon cancer cells. Cell Immunol. 2010;265:164-171. [PMID: 20851386 DOI: 10.1016/j.cellimm.2010.07.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
38 Aryappalli P, Shabbiri K, Masad RJ, Al-Marri RH, Haneefa SM, Mohamed YA, Arafat K, Attoub S, Cabral-Marques O, Ramadi KB, Fernandez-Cabezudo MJ, Al-Ramadi BK. Inhibition of Tyrosine-Phosphorylated STAT3 in Human Breast and Lung Cancer Cells by Manuka Honey is Mediated by Selective Antagonism of the IL-6 Receptor. Int J Mol Sci 2019;20:E4340. [PMID: 31491838 DOI: 10.3390/ijms20184340] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
39 Stabile LP, Farooqui M, Kanterewicz B, Abberbock S, Kurland BF, Diergaarde B, Siegfried JM. Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer. J Thorac Oncol 2018;13:399-412. [PMID: 29233790 DOI: 10.1016/j.jtho.2017.11.126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
40 Walschus U, Hoene A, Patrzyk M, Finke B, Polak M, Lucke S, Nebe B, Schroeder K, Podbielski A, Wilhelm L, Schlosser M. Serum profile of pro- and anti-inflammatory cytokines in rats following implantation of low-temperature plasma-modified titanium plates. J Mater Sci Mater Med 2012;23:1299-307. [PMID: 22402792 DOI: 10.1007/s10856-012-4600-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
41 Songür N, Kuru B, Kalkan F, Özdilekcan Ç, Çakmak H, Hızel N. Serum Interleukin-6 Levels Correlate with Malnutrition and Survival in Patients with Advanced Non-Small Cell Lung Cancer. Tumori 2004;90:196-200. [DOI: 10.1177/030089160409000207] [Cited by in Crossref: 53] [Cited by in F6Publishing: 25] [Article Influence: 17.7] [Reference Citation Analysis]
42 Nakamura H, Saji H, Ogata A, Hosaka M, Hagiwara M, Saijo T, Kawasaki N, Kato H. cDNA microarray analysis of gene expression in pathologic stage IA nonsmall cell lung carcinomas. Cancer 2003;97:2798-805. [DOI: 10.1002/cncr.11406] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
43 Wang L, Chang Y, Sun R, Li L. A multichannel smartphone optical biosensor for high-throughput point-of-care diagnostics. Biosensors and Bioelectronics 2017;87:686-92. [DOI: 10.1016/j.bios.2016.09.021] [Cited by in Crossref: 101] [Cited by in F6Publishing: 68] [Article Influence: 25.3] [Reference Citation Analysis]
44 Lee SO, Yang X, Duan S, Tsai Y, Strojny LR, Keng P, Chen Y. IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer. Oncotarget 2016;7:6626-38. [PMID: 26675547 DOI: 10.18632/oncotarget.6570] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 9.4] [Reference Citation Analysis]
45 Maeda Y, Takeuchi H, Matsuda S, Okamura A, Fukuda K, Miyasho T, Nakamura R, Suda K, Wada N, Kawakubo H, Kitagawa Y. Clinical significance of preoperative serum concentrations of interleukin-6 as a prognostic marker in patients with esophageal cancer. Esophagus 2020;17:279-88. [PMID: 31845119 DOI: 10.1007/s10388-019-00708-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
46 Tertis M, Leva PI, Bogdan D, Suciu M, Graur F, Cristea C. Impedimetric aptasensor for the label-free and selective detection of Interleukin-6 for colorectal cancer screening. Biosens Bioelectron 2019;137:123-32. [PMID: 31085401 DOI: 10.1016/j.bios.2019.05.012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 19.5] [Reference Citation Analysis]
47 Enewold L, Mechanic LE, Bowman ED, Zheng YL, Yu Z, Trivers G, Alberg AJ, Harris CC. Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 2009;18:215-22. [PMID: 19124500 DOI: 10.1158/1055-9965.EPI-08-0705] [Cited by in Crossref: 71] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
48 Wang G, Weng Y, Ishiguro Y, Sakamoto H, Morita S. The effect of tramadol on serum cytokine response in patients undergoing pulmonary lobectomy. Journal of Clinical Anesthesia 2005;17:444-50. [DOI: 10.1016/j.jclinane.2004.10.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
49 Rincon M, Broadwater G, Harris L, Crocker A, Weaver D, Dressler L, Berry D, Sutton L, Michaelson R, Messino M, Kirshner J, Fleming G, Winer E, Hudis C, Appel S, Norton L, Muss H; Cancer and Leukemia Group B. Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806. Breast Cancer Res Treat 2006;100:301-8. [PMID: 16773437 DOI: 10.1007/s10549-006-9251-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
50 Kuang Y, Wang Q. Iron and lung cancer. Cancer Letters 2019;464:56-61. [DOI: 10.1016/j.canlet.2019.08.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
51 Heikkilä K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health. 2007;61:824-833. [PMID: 17699539 DOI: 10.1136/jech.2006.051292] [Cited by in Crossref: 236] [Cited by in F6Publishing: 206] [Article Influence: 16.9] [Reference Citation Analysis]
52 Sarries C, Haura EB, Roig B, Taron M, Abad A, Scagliotti G, Rosell R. Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer. Pharmacogenomics 2002;3:763-80. [DOI: 10.1517/14622416.3.6.763] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
53 Gao SP, Mark KG, Leslie K, Pao W, Motoi N, Gerald WL, Travis WD, Bornmann W, Veach D, Clarkson B. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest. 2007;117:3846-3856. [PMID: 18060032 DOI: 10.1172/jci31871] [Cited by in Crossref: 467] [Cited by in F6Publishing: 283] [Article Influence: 35.9] [Reference Citation Analysis]
54 Nakano K, Sugiyama K, Satoh H, Shiromori S, Sugitate K, Arifuku H, Yoshida N, Watanabe H, Tokita S, Wakayama T, Tatewaki M, Souma R, Koyama K, Hirata H, Fukushima Y. Risk factors for disseminated intravascular coagulation in patients with lung cancer. Thorac Cancer 2018;9:931-8. [PMID: 29851300 DOI: 10.1111/1759-7714.12766] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
55 Moreira CC, Cassolla P, Dornellas AP, de Morais H, de Souza CO, Borba-Murad GR, Bazotte RB, de Souza HM. Changes in liver gluconeogenesis during the development of Walker-256 tumour in rats. Int J Exp Pathol 2013;94:47-55. [PMID: 23317353 DOI: 10.1111/iep.12002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
56 Ljungberg B, Grankvist K, Rasmuson T. Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma. Eur J Cancer 1997;33:1794-8. [PMID: 9470835 DOI: 10.1016/s0959-8049(97)00179-2] [Cited by in Crossref: 69] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
57 Im JY, Kim BK, Lee KW, Chun SY, Kang MJ, Won M. DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells. Oncogenesis 2020;9:1. [PMID: 31900385 DOI: 10.1038/s41389-019-0187-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
58 Wang L, Sun R, Vasile T, Chang Y, Li L. High-Throughput Optical Sensing Immunoassays on Smartphone. Anal Chem 2016;88:8302-8. [DOI: 10.1021/acs.analchem.6b02211] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 7.4] [Reference Citation Analysis]
59 Gosain R, Anwar S, Miller A, Iyer R, Mukherjee S. Interleukin-6 as a biomarker in patients with hepatobiliary cancers. J Gastrointest Oncol 2019;10:537-45. [PMID: 31183205 DOI: 10.21037/jgo.2019.01.09] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Carpagnano G, Resta O, Foschino-barbaro M, Gramiccioni E, Carpagnano F. Interleukin-6 is Increased in Breath Condensate of Patients with Non-Small Cell Lung Cancer. Int J Biol Markers 2002;17:141-5. [DOI: 10.1177/172460080201700211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
61 Shiga K, Hara M, Nagasaki T, Sato T, Takahashi H, Sato M, Takeyama H. Preoperative Serum Interleukin-6 Is a Potential Prognostic Factor for Colorectal Cancer, including Stage II Patients. Gastroenterol Res Pract 2016;2016:9701574. [PMID: 26858756 DOI: 10.1155/2016/9701574] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
62 Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso NE, Harris CC. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. J Natl Cancer Inst 2011;103:1112-22. [PMID: 21685357 DOI: 10.1093/jnci/djr216] [Cited by in Crossref: 194] [Cited by in F6Publishing: 176] [Article Influence: 19.4] [Reference Citation Analysis]
63 Wang LS, Chow KC, Wu CW. Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate. Br J Cancer 1999;80:1617-22. [PMID: 10408408 DOI: 10.1038/sj.bjc.6690571] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
64 Chung YC, Chang YF. Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol. 2003;83:222-226. [PMID: 12884234 DOI: 10.1002/jso.10269] [Cited by in Crossref: 211] [Cited by in F6Publishing: 191] [Article Influence: 11.7] [Reference Citation Analysis]
65 Hayama S, Okushiba S, Shichinohe T, Hirano S, Tanaka E, Kondo S. Esophageal carcinosarcoma presenting as a fever with elevated serum interleukin-6. Ann Thorac Surg. 2011;91:1288-1290. [PMID: 21440168 DOI: 10.1016/j.athoracsur.2010.09.064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
66 Song L, Turkson J, Karras JG, Jove R, Haura EB. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene 2003;22:4150-65. [PMID: 12833138 DOI: 10.1038/sj.onc.1206479] [Cited by in Crossref: 263] [Cited by in F6Publishing: 226] [Article Influence: 14.6] [Reference Citation Analysis]
67 Jablonska E, Piotrowski L, Grabowska Z. Serum Levels of IL-lβ, IL-6, TNF-α, sTNF-RI and CRP in Patients with oral cavity cancer. Pathol Oncol Res 1997;3:126-9. [DOI: 10.1007/bf02907807] [Cited by in Crossref: 68] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
68 Komura N, Mabuchi S, Yokoi E, Shimura K, Kawano M, Matsumoto Y, Kimura T. Pre-treatment prognostic nutritional index is superior to platelet count in predicting disease-specific survival in patients with epithelial ovarian cancer. Int J Gynecol Cancer 2019;29:1057-63. [PMID: 31203199 DOI: 10.1136/ijgc-2019-000492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Nakagoe T, Tsuji T, Sawai T, Tanaka K, Hidaka S, Shibasaki S, Nanashima A, Ohbatake M, Yamaguchi H, Yasutake T, Sugawara K, Inokuchi N, Kamihira S. Increased serum levels of interleukin-6 in malnourished patients with colorectal cancer. Cancer Letters 2003;202:109-15. [DOI: 10.1016/j.canlet.2003.09.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
70 Lai SY, Johnson FM. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches. Drug Resist Updat 2010;13:67-78. [PMID: 20471303 DOI: 10.1016/j.drup.2010.04.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 85] [Article Influence: 9.4] [Reference Citation Analysis]
71 Grimm C, Six L, Tomovski C, Speiser P, Joura E, Zeillinger R, Sliutz G, Reinthaller A, Hefler LA. A Common Interleukin-6 Promoter Polymorphism in Patients With Vulvar Cancer. Journal of the Society for Gynecologic Investigation 2016;12:617-20. [DOI: 10.1016/j.jsgi.2005.08.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
72 Barthelemy-Brichant N, Bosquée L, Cataldo D, Corhay JL, Gustin M, Seidel L, Thiry A, Ghaye B, Nizet M, Albert A, Deneufbourg JM, Bartsch P, Nusgens B. Increased IL-6 and TGF-beta1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. Int J Radiat Oncol Biol Phys 2004;58:758-67. [PMID: 14967431 DOI: 10.1016/S0360-3016(03)01614-6] [Cited by in Crossref: 66] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
73 Justino CI, Rocha-santos TA, Duarte AC, Rocha-santos TA. Advances in point-of-care technologies with biosensors based on carbon nanotubes. TrAC Trends in Analytical Chemistry 2013;45:24-36. [DOI: 10.1016/j.trac.2012.12.012] [Cited by in Crossref: 84] [Cited by in F6Publishing: 39] [Article Influence: 10.5] [Reference Citation Analysis]
74 Duan S, Tsai Y, Keng P, Chen Y, Lee SO, Chen Y. IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and DNA repair associated molecules. Oncotarget 2015;6:27651-60. [PMID: 26313152 DOI: 10.18632/oncotarget.4753] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 8.4] [Reference Citation Analysis]
75 Reitter EM, Ay C, Kaider A, Pirker R, Zielinski C, Zlabinger G, Pabinger I. Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients. Clin Exp Immunol 2014;177:253-60. [PMID: 24580121 DOI: 10.1111/cei.12308] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
76 Chang JW, Lee SH, Lu Y, Yoo YJ. Transforming growth factor-beta1 induces the non-classical secretion of peroxiredoxin-I in A549 cells. Biochem Biophys Res Commun 2006;345:118-23. [PMID: 16677601 DOI: 10.1016/j.bbrc.2006.04.073] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
77 Tan X, Carretero J, Chen Z, Zhang J, Wang Y, Chen J, Li X, Ye H, Tang C, Cheng X, Hou N, Yang X, Wong KK. Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer. PLoS One 2013;8:e80885. [PMID: 24260500 DOI: 10.1371/journal.pone.0080885] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
78 Ray K, Ujvari B, Ramana V, Donald J. Cross-talk between EGFR and IL-6 drives oncogenic signaling and offers therapeutic opportunities in cancer. Cytokine & Growth Factor Reviews 2018;41:18-27. [DOI: 10.1016/j.cytogfr.2018.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
79 Dunlop RJ, Campbell CW. Cytokines and Advanced Cancer. Journal of Pain and Symptom Management 2000;20:214-32. [DOI: 10.1016/s0885-3924(00)00199-8] [Cited by in Crossref: 91] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
80 Giannitrapani L, Cervello M, Soresi M, Notarbartolo M, La Rosa M, Virruso L, D'Alessandro N, Montalto G. Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma. Ann N Y Acad Sci. 2002;963:46-52. [PMID: 12095927 DOI: 10.1111/j.1749-6632.2002.tb04093.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 1.7] [Reference Citation Analysis]
81 Zhao M, Li X, Chen X. GOLM1 predicts poor prognosis of patients with NSCLC and is associated with the proliferation and chemo-sensitivity of cisplatin in NSCLC cells: bioinformatics analysis and laboratory validation. J Bioenerg Biomembr 2021;53:177-89. [PMID: 33538941 DOI: 10.1007/s10863-021-09875-7] [Reference Citation Analysis]
82 Tisdale MJ. Cancer cachexia: Metabolic alterations and clinical manifestations. Nutrition 1997;13:1-7. [DOI: 10.1016/s0899-9007(96)00313-9] [Cited by in Crossref: 111] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
83 Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89:1028-1030. [PMID: 12966420 DOI: 10.1038/sj.bjc.6601242] [Cited by in Crossref: 401] [Cited by in F6Publishing: 365] [Article Influence: 22.3] [Reference Citation Analysis]
84 Chang CH, Hsiao CF, Yeh YM, Chang GC, Tsai YH, Chen YM, Huang MS, Chen HL, Li YJ, Yang PC, Chen CJ, Hsiung CA, Su WC. Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy. Int J Cancer 2013;132:1977-85. [PMID: 23034889 DOI: 10.1002/ijc.27892] [Cited by in Crossref: 100] [Cited by in F6Publishing: 92] [Article Influence: 11.1] [Reference Citation Analysis]
85 Hao Z, Pan Y, Huang C, Wang Z, Zhao X. Sensitive detection of lung cancer biomarkers using an aptameric graphene-based nanosensor with enhanced stability. Biomed Microdevices 2019;21:65. [PMID: 31273548 DOI: 10.1007/s10544-019-0409-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
86 Adler G, Eichman W, Szczepanski M, Targonska I, Jasinska A. Postoperative Plasma Interleukin-6 in Patients with Renal Cancer Correlates with C-reactive Protein but Not with Total Fibrinogen or with High Molecular Weight Fibrinogen Fraction. Thrombosis Research 1998;89:243-8. [DOI: 10.1016/s0049-3848(98)00011-5] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
87 Lagiou P, Trichopoulos D. Inflammatory biomarkers and risk of lung cancer. J Natl Cancer Inst 2011;103:1073-5. [PMID: 21685358 DOI: 10.1093/jnci/djr220] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
88 Kasuga I, Makino S, Kiyokawa H, Katoh H, Ebihara Y, Ohyashiki K. Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer 2001;92:2399-405. [DOI: 10.1002/1097-0142(20011101)92:9<2399::aid-cncr1588>3.0.co;2-w] [Cited by in Crossref: 121] [Cited by in F6Publishing: 56] [Article Influence: 6.1] [Reference Citation Analysis]
89 Du Q, Li E, Liu Y, Xie W, Huang C, Song J, Zhang W, Zheng Y, Wang H, Wang Q. CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer. Cancer Med 2018;7:325-35. [PMID: 29356357 DOI: 10.1002/cam4.1292] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
90 Winck FV, Prado Ribeiro AC, Ramos Domingues R, Ling LY, Riaño-Pachón DM, Rivera C, Brandão TB, Gouvea AF, Santos-Silva AR, Coletta RD, Paes Leme AF. Insights into immune responses in oral cancer through proteomic analysis of saliva and salivary extracellular vesicles. Sci Rep 2015;5:16305. [PMID: 26538482 DOI: 10.1038/srep16305] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 10.2] [Reference Citation Analysis]
91 Lim RJ, Liu B, Krysan K, Dubinett SM. Lung Cancer and Immunity Markers. Cancer Epidemiol Biomarkers Prev 2020;29:2423-30. [PMID: 32856614 DOI: 10.1158/1055-9965.EPI-20-0716] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Kayacan O, Karnak D, Beder S, Güllü E, Tutkak H, Şenler FÇ, Köksal D. Impact of TNF-α and IL-6 Levels on Development of Cachexia in Newly Diagnosed NSCLC Patients. American Journal of Clinical Oncology 2006;29:328-35. [DOI: 10.1097/01.coc.0000221300.72657.e0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
93 Lee JY, Talhi O, Jang D, Cerella C, Gaigneaux A, Kim KW, Lee JW, Dicato M, Bachari K, Han BW, Silva AMS, Orlikova B, Diederich M. Cytostatic hydroxycoumarin OT52 induces ER/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancer. Cancer Lett 2018;416:94-108. [PMID: 29247826 DOI: 10.1016/j.canlet.2017.12.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
94 Reyes-García J, Montaño LM, Carbajal-García A, Wang YX. Sex Hormones and Lung Inflammation. Adv Exp Med Biol 2021;1304:259-321. [PMID: 34019274 DOI: 10.1007/978-3-030-68748-9_15] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Zhao J, Liu J, Lee JF, Zhang W, Kandouz M, VanHecke GC, Chen S, Ahn YH, Lonardo F, Lee MJ. TGF-β/SMAD3 Pathway Stimulates Sphingosine-1 Phosphate Receptor 3 Expression: IMPLICATION OF SPHINGOSINE-1 PHOSPHATE RECEPTOR 3 IN LUNG ADENOCARCINOMA PROGRESSION. J Biol Chem 2016;291:27343-53. [PMID: 27856637 DOI: 10.1074/jbc.M116.740084] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
96 Haura EB, Livingston S, Coppola D. Autocrine Interleukin-6/Interleukin-6 Receptor Stimulation in Non–Small-Cell Lung Cancer. Clinical Lung Cancer 2006;7:273-5. [DOI: 10.3816/clc.2006.n.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
97 Le Naour F, Brichory F, Beretta L, Hanash SM. Identification of Tumor-Associated Antigens Using Proteomics. Technol Cancer Res Treat 2002;1:257-62. [DOI: 10.1177/153303460200100406] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
98 Gomes M, Teixeira AL, Coelho A, Araújo A, Medeiros R. The Role of Inflammation in Lung Cancer. In: Aggarwal BB, Sung B, Gupta SC, editors. Inflammation and Cancer. Basel: Springer; 2014. pp. 1-23. [DOI: 10.1007/978-3-0348-0837-8_1] [Cited by in Crossref: 101] [Cited by in F6Publishing: 98] [Article Influence: 14.4] [Reference Citation Analysis]
99 Yoshida Y, Sibusa T, Ishii Y, Akino K, Kikuchi T, Mita H, Adachi Y, Nakamura M, Adachi Y, Kato Y, Endo T. Granulocyte Colony-stimulating Factor- and Interleukin-6-producing Large-cell Carcinoma of the Lung with Sarcomatoid Changes Suggestive of Epithelial-mesenchymal Transition: An Autopsy Case Report. Intern Med 2019;58:3305-11. [PMID: 31366794 DOI: 10.2169/internalmedicine.2819-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
100 Dowlati A, Levitan N, Remick SC. Evaluation of interleukin-6 in bronchoalveolar lavage fluid and serum of patients with lung cancer. J Lab Clin Med 1999;134:405-9. [PMID: 10521088 DOI: 10.1016/s0022-2143(99)90156-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
101 Pine SR, Mechanic LE, Enewold L, Bowman ED, Ryan BM, Cote ML, Wenzlaff AS, Loffredo CA, Olivo-Marston S, Chaturvedi A, Caporaso NE, Schwartz AG, Harris CC. Differential Serum Cytokine Levels and Risk of Lung Cancer Between African and European Americans. Cancer Epidemiol Biomarkers Prev 2016;25:488-97. [PMID: 26711330 DOI: 10.1158/1055-9965.EPI-15-0378] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
102 Brussino L, Culla B, Bucca C, Giobbe R, Boita M, Isaia G, Heffler E, Oliaro A, Filosso P, Rolla G. Inflammatory cytokines and VEGF measured in exhaled breath condensate are correlated with tumor mass in non-small cell lung cancer. J Breath Res 2014;8:027110. [PMID: 24861949 DOI: 10.1088/1752-7155/8/2/027110] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
103 Pazhouhandeh M, Samiee F, Boniadi T, Khedmat AF, Vahedi E, Mirdamadi M, Sigari N, Siadat SD, Vaziri F, Fateh A, Ajorloo F, Tafsiri E, Ghanei M, Mahboudi F, Rahimi Jamnani F. Comparative Network Analysis of Patients with Non-Small Cell Lung Cancer and Smokers for Representing Potential Therapeutic Targets. Sci Rep 2017;7:13812. [PMID: 29062084 DOI: 10.1038/s41598-017-14195-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
104 Tsai HY, Boonyapranai K, Sriyam S, Yu CJ, Wu SW, Khoo KH, Phutrakul S, Chen ST. Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer. Proteomics 2011;11:2162-70. [PMID: 21538882 DOI: 10.1002/pmic.201000319] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
105 Soresi M, Giannitrapani L, D'Antona F, Florena AM, La Spada E, Terranova A, Cervello M, D'Alessandro N, Montalto G. Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. World J Gastroenterol. 2006;12:2563-2568. [PMID: 16688802 DOI: 10.3748/wjg.v12.i16] [Reference Citation Analysis]
106 Ardestani SK, Inserra P, Solkoff D, Watson RR. The Role of Cytokines and Chemokines on Tumor Progression: A Review. Cancer Detect Prev 1999;23:215-25. [DOI: 10.1046/j.1525-1500.1999.99021.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
107 Alexandrakis MG, Passam FH, Perisinakis K, Ganotakis E, Margantinis G, Kyriakou DS, Bouros D. Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis. Respir Med 2002;96:553-8. [PMID: 12195834 DOI: 10.1053/rmed.2002.1328] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
108 Glojnarić I, Casl MT, Simić D, Lukac J. Serum amyloid A protein (SAA) in colorectal carcinoma. Clin Chem Lab Med 2001;39:129-33. [PMID: 11341746 DOI: 10.1515/CCLM.2001.022] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
109 Wang Y, Chang S, Tai S, Li W, Wang L. Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma. Head Neck 2002;24:850-8. [DOI: 10.1002/hed.10145] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
110 Mikhailidis DP, Ganotakis ES. Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets. 1996;7:125-137. [PMID: 21043591 DOI: 10.3109/09537109609023571] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
111 Li YY, Hsieh LL, Tang RP, Liao SK, Yeh KY. Interleukin-6 (IL-6) released by macrophages induces IL-6 secretion in the human colon cancer HT-29 cell line. Hum Immunol. 2009;70:151-158. [PMID: 19272324 DOI: 10.1016/j.humimm.2009.01.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
112 Martínez-García D, Pérez-Hernández M, Korrodi-Gregório L, Quesada R, Ramos R, Baixeras N, Pérez-Tomás R, Soto-Cerrato V. The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models. Biomolecules 2019;9:E361. [PMID: 31412593 DOI: 10.3390/biom9080361] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
113 Miller A, Brooks GD, Mcleod L, Ruwanpura S, Jenkins BJ. Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis. Oncogene 2015;34:1510-9. [DOI: 10.1038/onc.2014.99] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
114 To Y, Dohi M, Matsumoto K, Tanaka R, Sato A, Nakagome K, Nakamura T, Yamamoto K. A Two-way Interaction between Hepatocyte Growth Factor and Interleukin-6 in Tissue Invasion of Lung Cancer Cell Line. Am J Respir Cell Mol Biol 2002;27:220-6. [DOI: 10.1165/ajrcmb.27.2.4804] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
115 Keeley BR, Islami F, Pourshams A, Poustchi H, Pak JS, Brennan P, Khademi H, Genden EM, Abnet CC, Dawsey SM, Boffetta P, Malekzadeh R, Sikora AG. Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer. Cancer Sci 2014;105:1205-11. [PMID: 25040886 DOI: 10.1111/cas.12485] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
116 Carter C. Alterations in Blood Components. Comprehensive Toxicology. Elsevier; 2018. pp. 249-93. [DOI: 10.1016/b978-0-12-801238-3.64251-4] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]